CN1214785C - 一种用于保护眼睛的透皮控穴位贴片及其制备方法 - Google Patents
一种用于保护眼睛的透皮控穴位贴片及其制备方法 Download PDFInfo
- Publication number
- CN1214785C CN1214785C CNB031564178A CN03156417A CN1214785C CN 1214785 C CN1214785 C CN 1214785C CN B031564178 A CNB031564178 A CN B031564178A CN 03156417 A CN03156417 A CN 03156417A CN 1214785 C CN1214785 C CN 1214785C
- Authority
- CN
- China
- Prior art keywords
- extract
- medicine
- chinese medicine
- preparation
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 52
- 239000011505 plaster Substances 0.000 title abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 160
- 238000001467 acupuncture Methods 0.000 claims abstract description 146
- 210000001508 eye Anatomy 0.000 claims abstract description 83
- 229940079593 drug Drugs 0.000 claims abstract description 32
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims abstract description 20
- 239000004744 fabric Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 239000010410 layer Substances 0.000 claims description 53
- 238000012545 processing Methods 0.000 claims description 34
- 239000000839 emulsion Substances 0.000 claims description 29
- 241000628997 Flos Species 0.000 claims description 26
- 229920002799 BoPET Polymers 0.000 claims description 21
- 239000005041 Mylar™ Substances 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 20
- 239000011248 coating agent Substances 0.000 claims description 19
- 238000000576 coating method Methods 0.000 claims description 19
- 238000013270 controlled release Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000011241 protective layer Substances 0.000 claims description 11
- 238000012546 transfer Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 8
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 7
- 244000178870 Lavandula angustifolia Species 0.000 claims description 7
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 7
- 238000013019 agitation Methods 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 239000003961 penetration enhancing agent Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 235000013599 spices Nutrition 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 239000000080 wetting agent Substances 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 6
- 230000005611 electricity Effects 0.000 claims description 6
- 229920001296 polysiloxane Polymers 0.000 claims description 6
- 238000004078 waterproofing Methods 0.000 claims description 6
- 238000005269 aluminizing Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 210000005036 nerve Anatomy 0.000 abstract description 13
- 210000003205 muscle Anatomy 0.000 abstract description 12
- 210000004204 blood vessel Anatomy 0.000 abstract description 11
- 238000003860 storage Methods 0.000 abstract description 4
- 230000002085 persistent effect Effects 0.000 abstract description 2
- 229920000728 polyester Polymers 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- 239000004411 aluminium Substances 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 45
- 230000017531 blood circulation Effects 0.000 description 21
- 241000196324 Embryophyta Species 0.000 description 18
- 230000004089 microcirculation Effects 0.000 description 15
- 239000008280 blood Substances 0.000 description 14
- 238000002347 injection Methods 0.000 description 14
- 239000007924 injection Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 5
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000010253 intravenous injection Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 4
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003727 cerebral blood flow Effects 0.000 description 4
- 210000000795 conjunctiva Anatomy 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000002045 lasting effect Effects 0.000 description 4
- 210000003470 mitochondria Anatomy 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 206010000059 abdominal discomfort Diseases 0.000 description 3
- 208000003464 asthenopia Diseases 0.000 description 3
- 230000001886 ciliary effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 3
- 229940114124 ferulic acid Drugs 0.000 description 3
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 3
- 235000001785 ferulic acid Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 2
- 230000004410 intraocular pressure Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000008058 pain sensation Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 201000010041 presbyopia Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000004436 pseudomyopia Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- -1 Lipid peroxide Chemical class 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000003446 pia mater Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000000331 sympathetic ganglia Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008337 systemic blood flow Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/023—Adhesive plasters or dressings wound covering film layers without a fluid handling layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00446—Plasters use for oriental medicine
Abstract
Description
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40655702P | 2002-08-27 | 2002-08-27 | |
US60/406.557 | 2002-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1494901A CN1494901A (zh) | 2004-05-12 |
CN1214785C true CN1214785C (zh) | 2005-08-17 |
Family
ID=34272305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031564178A Expired - Lifetime CN1214785C (zh) | 2002-08-27 | 2003-08-26 | 一种用于保护眼睛的透皮控穴位贴片及其制备方法 |
Country Status (2)
Country | Link |
---|---|
US (2) | US7645462B2 (zh) |
CN (1) | CN1214785C (zh) |
Families Citing this family (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7479133B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating acne and rosacea with galvanic generated electricity |
US7507228B2 (en) * | 2003-06-30 | 2009-03-24 | Johnson & Johnson Consumer Companies, Inc. | Device containing a light emitting diode for treatment of barrier membranes |
US7486989B2 (en) * | 2003-06-30 | 2009-02-03 | Johnson & Johnson Consumer Companies, Inc. | Device for delivery of oxidizing agents to barrier membranes |
US7476222B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of reducing the appearance of pigmentation with galvanic generated electricity |
US8734421B2 (en) * | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
US7477939B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating a wound with galvanic generated electricity |
US7477938B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Cosumer Companies, Inc. | Device for delivery of active agents to barrier membranes |
US7477941B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of exfoliating the skin with electricity |
US7477940B2 (en) * | 2003-06-30 | 2009-01-13 | J&J Consumer Companies, Inc. | Methods of administering an active agent to a human barrier membrane with galvanic generated electricity |
US7480530B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Device for treatment of barrier membranes |
US20040265395A1 (en) * | 2003-06-30 | 2004-12-30 | Ying Sun | Device for delivery of reducing agents to barrier membranes |
GB2414675B (en) * | 2004-06-05 | 2006-09-06 | Dewan Fazlul Hoque Chowdhury | Transdermal drug delivery device |
US20060068032A1 (en) * | 2004-09-24 | 2006-03-30 | Sunny Biodiscovery, Inc. | Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of Angelica sinensis, and methods of preparation thereof |
GB2435426A (en) * | 2006-02-23 | 2007-08-29 | David William Richardson | Wound healing system and dressing containing a dried form of a liquid |
EP1839705A1 (en) | 2006-03-27 | 2007-10-03 | Universidad de Alcala | Transcutaneous laser therapy patch |
CA2701009C (en) * | 2007-09-28 | 2017-03-21 | Johnson & Johnson Consumer Companies, Inc. | Electricity-generating particulates and the use thereof |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
JP5015872B2 (ja) | 2008-07-16 | 2012-08-29 | 日東電工株式会社 | 貼付剤の製造方法 |
US20100082088A1 (en) * | 2008-08-27 | 2010-04-01 | Ali Fassih | Treatment of sweating and hyperhydrosis |
US8150525B2 (en) * | 2008-08-27 | 2012-04-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment of hyperhydrosis |
WO2010039381A1 (en) * | 2008-09-30 | 2010-04-08 | Teikoku Pharma Usa, Inc. | Transdermal extended-delivery donepezil compositions and methods for using the same |
CN101766695B (zh) * | 2009-01-06 | 2012-07-04 | 天津奥克莱斯生物技术有限公司 | 一种穴位眼贴及其制备方法和应用 |
GB2467377A (en) * | 2009-02-02 | 2010-08-04 | Nemaura Pharma Ltd | Transdermal patch with extensor means actuated to expel drug towards the skin of a patient |
US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
CA2780537A1 (en) | 2009-11-13 | 2011-05-19 | Johnson & Johnson Consumer Companies, Inc. | Galvanic skin treatment device |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
KR20110091461A (ko) * | 2010-02-05 | 2011-08-11 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 갈바니 미립자를 포함하는 립 조성물 |
CN102781406B (zh) * | 2010-03-01 | 2015-07-08 | 强生消费者公司 | 具有理想的整体颜色的护肤组合物 |
US20110236491A1 (en) * | 2010-03-25 | 2011-09-29 | Jeannette Chantalat | Topical anti-inflammatory composition |
CN101890079B (zh) * | 2010-04-29 | 2014-08-06 | 贵阳春科药业技术研发有限公司 | 防治鼻炎的药物制剂及其制备方法 |
MX2014000392A (es) | 2011-07-12 | 2014-04-30 | Mobli Technologies 2010 Ltd | Metodos y sistemas para proporcionar funciones de edicion de contenido visual. |
CN103127243A (zh) * | 2011-11-22 | 2013-06-05 | 吉林省第二荣复军人医院 | 一种治疗急慢性肝炎及肝脏疾病引起的转氨酶升高疾病的药物 |
US20130171200A1 (en) * | 2011-12-30 | 2013-07-04 | Tuming You | Heat Patch for Diabetes |
US11734712B2 (en) | 2012-02-24 | 2023-08-22 | Foursquare Labs, Inc. | Attributing in-store visits to media consumption based on data collected from user devices |
CN104644747A (zh) * | 2013-11-15 | 2015-05-27 | 王文革 | 一种主要用于治疗假性近视的敷眼液 |
US10238847B2 (en) | 2014-01-22 | 2019-03-26 | Geelux Holdings, Ltd. | Devices and methods for transdermal drug delivery |
IL239238B (en) | 2014-06-05 | 2022-04-01 | Mobli Tech 2010 Ltd | Automatic enrichment of advertising with the help of social network trends |
US9113301B1 (en) | 2014-06-13 | 2015-08-18 | Snapchat, Inc. | Geo-location based event gallery |
US9225897B1 (en) | 2014-07-07 | 2015-12-29 | Snapchat, Inc. | Apparatus and method for supplying content aware photo filters |
CN104146875B (zh) * | 2014-08-06 | 2017-06-23 | 珠海横琴早晨科技有限公司 | 一种多功能自发调节温度立体面膜 |
US10423983B2 (en) | 2014-09-16 | 2019-09-24 | Snap Inc. | Determining targeting information based on a predictive targeting model |
US10824654B2 (en) | 2014-09-18 | 2020-11-03 | Snap Inc. | Geolocation-based pictographs |
US9015285B1 (en) | 2014-11-12 | 2015-04-21 | Snapchat, Inc. | User interface for accessing media at a geographic location |
US10311916B2 (en) | 2014-12-19 | 2019-06-04 | Snap Inc. | Gallery of videos set to an audio time line |
US9385983B1 (en) | 2014-12-19 | 2016-07-05 | Snapchat, Inc. | Gallery of messages from individuals with a shared interest |
US9754355B2 (en) | 2015-01-09 | 2017-09-05 | Snap Inc. | Object recognition based photo filters |
US11388226B1 (en) | 2015-01-13 | 2022-07-12 | Snap Inc. | Guided personal identity based actions |
US9692967B1 (en) | 2015-03-23 | 2017-06-27 | Snap Inc. | Systems and methods for reducing boot time and power consumption in camera systems |
US9881094B2 (en) | 2015-05-05 | 2018-01-30 | Snap Inc. | Systems and methods for automated local story generation and curation |
US10135949B1 (en) | 2015-05-05 | 2018-11-20 | Snap Inc. | Systems and methods for story and sub-story navigation |
US9652896B1 (en) | 2015-10-30 | 2017-05-16 | Snap Inc. | Image based tracking in augmented reality systems |
CN105411755A (zh) * | 2015-11-17 | 2016-03-23 | 桐乡市施康制药厂有限公司 | 一种医用胶布的制作工艺 |
US10474321B2 (en) | 2015-11-30 | 2019-11-12 | Snap Inc. | Network resource location linking and visual content sharing |
US9984499B1 (en) | 2015-11-30 | 2018-05-29 | Snap Inc. | Image and point cloud based tracking and in augmented reality systems |
US10285001B2 (en) | 2016-02-26 | 2019-05-07 | Snap Inc. | Generation, curation, and presentation of media collections |
US10339365B2 (en) | 2016-03-31 | 2019-07-02 | Snap Inc. | Automated avatar generation |
CN106063743A (zh) * | 2016-05-24 | 2016-11-02 | 深圳市本恩生物科技有限公司 | 中草药无纺布及其制备方法 |
US20170366965A1 (en) * | 2016-06-21 | 2017-12-21 | Chiun Mai Communication Systems, Inc. | Communication device, communication system and method therefor |
US10432559B2 (en) | 2016-10-24 | 2019-10-01 | Snap Inc. | Generating and displaying customized avatars in electronic messages |
CN112738408B (zh) | 2016-11-07 | 2022-09-16 | 斯纳普公司 | 图像修改器的选择性识别和排序 |
US10203855B2 (en) | 2016-12-09 | 2019-02-12 | Snap Inc. | Customized user-controlled media overlays |
CN106728937A (zh) * | 2016-12-16 | 2017-05-31 | 潘永锋 | 一种治疗眼疾的中药 |
US11616745B2 (en) | 2017-01-09 | 2023-03-28 | Snap Inc. | Contextual generation and selection of customized media content |
US11250075B1 (en) | 2017-02-17 | 2022-02-15 | Snap Inc. | Searching social media content |
US10074381B1 (en) | 2017-02-20 | 2018-09-11 | Snap Inc. | Augmented reality speech balloon system |
US10565795B2 (en) | 2017-03-06 | 2020-02-18 | Snap Inc. | Virtual vision system |
US10523625B1 (en) | 2017-03-09 | 2019-12-31 | Snap Inc. | Restricted group content collection |
US10581782B2 (en) | 2017-03-27 | 2020-03-03 | Snap Inc. | Generating a stitched data stream |
US10582277B2 (en) | 2017-03-27 | 2020-03-03 | Snap Inc. | Generating a stitched data stream |
US10387730B1 (en) | 2017-04-20 | 2019-08-20 | Snap Inc. | Augmented reality typography personalization system |
KR20220141927A (ko) | 2017-04-27 | 2022-10-20 | 스냅 인코포레이티드 | 지도-기반 소셜 미디어 플랫폼들에 대한 위치 프라이버시 관리 |
US10212541B1 (en) | 2017-04-27 | 2019-02-19 | Snap Inc. | Selective location-based identity communication |
US10803120B1 (en) | 2017-05-31 | 2020-10-13 | Snap Inc. | Geolocation based playlists |
US10740974B1 (en) | 2017-09-15 | 2020-08-11 | Snap Inc. | Augmented reality system |
US10499191B1 (en) | 2017-10-09 | 2019-12-03 | Snap Inc. | Context sensitive presentation of content |
US11265273B1 (en) | 2017-12-01 | 2022-03-01 | Snap, Inc. | Dynamic media overlay with smart widget |
CN107875370B (zh) * | 2017-12-19 | 2020-12-29 | 深圳健安医药有限公司 | 用于促进肠蠕动排气防止肠粘连的中药组合物及制备方法 |
US10678818B2 (en) | 2018-01-03 | 2020-06-09 | Snap Inc. | Tag distribution visualization system |
US11507614B1 (en) | 2018-02-13 | 2022-11-22 | Snap Inc. | Icon based tagging |
US10979752B1 (en) | 2018-02-28 | 2021-04-13 | Snap Inc. | Generating media content items based on location information |
US10327096B1 (en) | 2018-03-06 | 2019-06-18 | Snap Inc. | Geo-fence selection system |
US10933311B2 (en) | 2018-03-14 | 2021-03-02 | Snap Inc. | Generating collectible items based on location information |
CN108371632A (zh) * | 2018-03-22 | 2018-08-07 | 曹洪乾 | 靖眩膏 |
US10219111B1 (en) | 2018-04-18 | 2019-02-26 | Snap Inc. | Visitation tracking system |
US10679393B2 (en) | 2018-07-24 | 2020-06-09 | Snap Inc. | Conditional modification of augmented reality object |
US10997760B2 (en) | 2018-08-31 | 2021-05-04 | Snap Inc. | Augmented reality anthropomorphization system |
US10698583B2 (en) | 2018-09-28 | 2020-06-30 | Snap Inc. | Collaborative achievement interface |
CN109528931A (zh) * | 2018-11-28 | 2019-03-29 | 菲皇(广州)生物科技有限公司 | 一种眼部冷敷贴内含物配方及冷敷贴制备方法、应用 |
US10939236B1 (en) | 2018-11-30 | 2021-03-02 | Snap Inc. | Position service to determine relative position to map features |
US11199957B1 (en) | 2018-11-30 | 2021-12-14 | Snap Inc. | Generating customized avatars based on location information |
CN109342636A (zh) * | 2018-12-03 | 2019-02-15 | 国药集团新疆制药有限公司 | 一种复方雪莲胶囊成份鉴别方法 |
US10939246B1 (en) | 2019-01-16 | 2021-03-02 | Snap Inc. | Location-based context information sharing in a messaging system |
US11294936B1 (en) | 2019-01-30 | 2022-04-05 | Snap Inc. | Adaptive spatial density based clustering |
US10838599B2 (en) | 2019-02-25 | 2020-11-17 | Snap Inc. | Custom media overlay system |
US10964082B2 (en) | 2019-02-26 | 2021-03-30 | Snap Inc. | Avatar based on weather |
CN109700889A (zh) * | 2019-03-05 | 2019-05-03 | 朱月新 | 一种保健眼睛的中药组合物及其制备方法 |
US11249614B2 (en) | 2019-03-28 | 2022-02-15 | Snap Inc. | Generating personalized map interface with enhanced icons |
CN109966340A (zh) * | 2019-05-14 | 2019-07-05 | 河北安耐哲新能源技术有限公司 | 一种用于眼部的外用中药组合物及其制备方法和应用 |
US10560898B1 (en) | 2019-05-30 | 2020-02-11 | Snap Inc. | Wearable device location systems |
US10582453B1 (en) | 2019-05-30 | 2020-03-03 | Snap Inc. | Wearable device location systems architecture |
US11307747B2 (en) | 2019-07-11 | 2022-04-19 | Snap Inc. | Edge gesture interface with smart interactions |
US11218838B2 (en) | 2019-10-31 | 2022-01-04 | Snap Inc. | Focused map-based context information surfacing |
CN110946847A (zh) * | 2019-11-04 | 2020-04-03 | 上海交通大学医学院附属瑞金医院卢湾分院 | 一种局部外敷药物贴膜 |
US11128715B1 (en) | 2019-12-30 | 2021-09-21 | Snap Inc. | Physical friend proximity in chat |
US11429618B2 (en) | 2019-12-30 | 2022-08-30 | Snap Inc. | Surfacing augmented reality objects |
US11343323B2 (en) | 2019-12-31 | 2022-05-24 | Snap Inc. | Augmented reality objects registry |
US11228551B1 (en) | 2020-02-12 | 2022-01-18 | Snap Inc. | Multiple gateway message exchange |
US11516167B2 (en) | 2020-03-05 | 2022-11-29 | Snap Inc. | Storing data based on device location |
US10956743B1 (en) | 2020-03-27 | 2021-03-23 | Snap Inc. | Shared augmented reality system |
US11503432B2 (en) | 2020-06-15 | 2022-11-15 | Snap Inc. | Scalable real-time location sharing framework |
US11314776B2 (en) | 2020-06-15 | 2022-04-26 | Snap Inc. | Location sharing using friend list versions |
US11290851B2 (en) | 2020-06-15 | 2022-03-29 | Snap Inc. | Location sharing using offline and online objects |
CN111616953A (zh) * | 2020-06-24 | 2020-09-04 | 福建三和济医疗器械有限公司 | 一种用于穴位贴敷的治疗贴 |
CN112121103B (zh) * | 2020-09-28 | 2021-10-22 | 杭州市余杭区第五人民医院 | 一种防控学生近视中药熏蒸贴及制备方法 |
CN112263389A (zh) * | 2020-11-17 | 2021-01-26 | 中山大学中山眼科中心 | 一种眼科药灸贴 |
CN112717062B (zh) * | 2021-03-04 | 2021-12-07 | 上海中医药大学附属龙华医院 | 治疗糖尿病视网膜病变的中药组合物 |
US11606756B2 (en) | 2021-03-29 | 2023-03-14 | Snap Inc. | Scheduling requests for location data |
CN115089633B (zh) * | 2022-07-04 | 2023-10-24 | 兰守夕 | 一种防治近视的组合物、眼贴及制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR840002646A (ko) * | 1981-12-09 | 1984-07-16 | 고니시 진우에몬 | 구급용 반창고 |
IE53703B1 (en) * | 1982-12-13 | 1989-01-18 | Elan Corp Plc | Drug delivery device |
US5162037A (en) * | 1988-04-01 | 1992-11-10 | Whitson Laboratories, Inc. | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
CN1113149A (zh) * | 1994-06-23 | 1995-12-13 | 田树银 | 消炎灵及其制造方法 |
US5736154A (en) * | 1996-03-11 | 1998-04-07 | Fuisz Technologies Ltd. | Transdermal delivery system |
WO1999026571A1 (en) * | 1997-11-25 | 1999-06-03 | Theratech, Inc. | Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties |
JP2000044481A (ja) * | 1998-07-30 | 2000-02-15 | Sunstar Inc | 皮膚外用剤 |
KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
WO2002026726A2 (en) * | 2000-09-26 | 2002-04-04 | The Johns Hopkins University | Antiviral compositions and methods of use |
US6638981B2 (en) * | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
-
2003
- 2003-08-26 US US10/648,026 patent/US7645462B2/en not_active Expired - Fee Related
- 2003-08-26 CN CNB031564178A patent/CN1214785C/zh not_active Expired - Lifetime
-
2007
- 2007-07-31 US US11/831,588 patent/US20080021421A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040043062A1 (en) | 2004-03-04 |
US7645462B2 (en) | 2010-01-12 |
US20080021421A1 (en) | 2008-01-24 |
CN1494901A (zh) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1214785C (zh) | 一种用于保护眼睛的透皮控穴位贴片及其制备方法 | |
CN101766695B (zh) | 一种穴位眼贴及其制备方法和应用 | |
CN1301666C (zh) | 一种能增强免疫力的保健食品及其制备方法 | |
CN101411853B (zh) | 健脑醒神保健药枕 | |
CN103393591A (zh) | 香体酵素沐浴露 | |
CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
CN101972376A (zh) | 一种治疗椎间盘骨质增生的中药膏剂及其制备方法 | |
CN108771707A (zh) | 一种用于足底贴敷防治偏头痛的组合物以及使用方法 | |
CN106109792A (zh) | 一种治疗骨折软组织损伤中药微针透皮给药贴及制备方法 | |
CN101156849B (zh) | 一种促牙周再生的苯妥英钠缓释凝胶及其制备方法与应用 | |
CN105168446A (zh) | 一种治疗眼部疾病的中药组合物、眼部美容添加包及其制备方法 | |
CN1053358A (zh) | 系列透皮诊疗电子药贴 | |
CN102058841B (zh) | 一种治疗高血压的脐部外用药及其制备方法 | |
CN102058862B (zh) | 一种小儿脐部外用药及其制备方法 | |
CN1037151C (zh) | 参菊降压组合物的制备方法 | |
CN106421120A (zh) | 一种治疗飞蚊症的中药熏蒸液及其制备方法 | |
CN1131680C (zh) | 组合保健鞋垫 | |
CN2146987Y (zh) | 耳穴贴压治疗膜 | |
CN1824246A (zh) | 一种治冠心病心绞痛防心肌梗塞药膜背心药膜贴及制备法 | |
CN101028552A (zh) | 蜂胶药豆颈椎枕 | |
CN1785240A (zh) | 一种用于治疗冠心脏病类的滴丸剂及其制备方法 | |
CN107551054A (zh) | 糖痹外洗方组合物、其制备方法及其应用 | |
CN108310096A (zh) | 一种泡脚祛湿的配方 | |
CN108619042A (zh) | 一种活血化瘀乳房营养保健用化妆品及其制作方法 | |
CN100512865C (zh) | 治疗高血压的外用药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HU'NAN QIU ZEYOU PATENT STRATEGIC PLANNING CO., LT Free format text: FORMER OWNER: QIU ZEYOU Effective date: 20101029 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410011 28/F, SHUNTIANCHENG, NO.59, SECTION 2 OF FURONG MIDDLE ROAD, CHANGSHA CITY, HU'NAN PROVINCE TO: 410205 JUXING INDUSTRY BASE, NO.8, LUJING ROAD, CHANGSHA HIGH-TECH. DEVELOPMENT ZONE, YUELU DISTRICT, CHANGSHA CITY, HU'NAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101105 Address after: 300384 Tianjin City Huayuan Industrial Zone Ziyuan Road No. 6 B block 201 Patentee after: Tianjin Aokelaisi Bio-Technology Co.,Ltd. Address before: 100011 Beijing city Dongcheng District An Wai Avenue No. 116 Patentee before: Sun Liqin |
|
PP01 | Preservation of patent right |
Effective date of registration: 20150625 Granted publication date: 20050817 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20160625 Granted publication date: 20050817 |
|
PP01 | Preservation of patent right |
Effective date of registration: 20160625 Granted publication date: 20050817 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20161225 Granted publication date: 20050817 |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20171225 Granted publication date: 20050817 Date of cancellation: 20170625 Granted publication date: 20050817 |
|
PD01 | Discharge of preservation of patent | ||
PP01 | Preservation of patent right |
Effective date of registration: 20161225 Granted publication date: 20050817 Effective date of registration: 20170625 Granted publication date: 20050817 Effective date of registration: 20171225 Granted publication date: 20050817 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20180625 Granted publication date: 20050817 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20180625 Granted publication date: 20050817 |
|
CX01 | Expiry of patent term |
Granted publication date: 20050817 |
|
CX01 | Expiry of patent term | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230826 Granted publication date: 20050817 |